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Burden and presentation of depression
among newly diagnosed individuals with
TB in primary care settings in Ethiopia
Fentie Ambaw1,2*, Rosie Mayston3, Charlotte Hanlon2,3 and Atalay Alem2
Abstract
Background: Understanding co-morbidity of depression and tuberculosis (TB) has been limited by challenges in
measurement of depression due to overlapping symptoms, use of small hospital samples and uncontrolled analysis.
This study was conducted to better understand the burden and presentation of depression, and associated factors
in people with TB in primary care settings in Ethiopia.
Methods: We conducted a cross-sectional survey among 657 people newly diagnosed with TB. Symptoms of
depression were measured using the Patient Health Questionnaire (PHQ-9). TB symptoms and other factors were
captured using standardised questionnaires. The factor structure of PHQ-9 was examined. Multivariable analysis was
carried out to estimate prevalence ratios.
Results: The prevalence of probable depression was 54.0%. The PHQ-9 had one factor structure (alpha = 0.81). Little
interest or pleasure in doing things (73.0%) was the commonest depressive symptom. Older age (Adjusted Prevalence
ratio (APR) = 1.19; 95%CI = 1.06, 1.33), female sex (APR = 1.23; 95%CI = 1.18, 1.27), night sweating (APR = 1.25; 95%CI = 1.16,
1.35), pain (APR = 1.69; 95%CI = 1.24, 2.29), being underweight (APR = 1.10; 95%CI = 1.07, 1.13), duration of illness
(APR = 1.35; 95%CI = 1.22, 1.50), level of education (APR = 0.93; 95%CI = 0.90, 0.95), and social support (APR = 0.89;
95%CI = 0.85, 0.93) were independently associated with probable depression.
Conclusions: Depression appears highly prevalent in people with TB and PHQ-9 seems to be a useful instrument
to detect depression in the context of TB. The frequency of depressive symptoms would suggest that the occurrence
of the symptoms in people with TB is in the usual manifestation of the disorder. Prospective studies are needed to
understand the longitudinal relationship between TB and depression.
Keywords: Depression, Tuberculosis, Primary care, Ethiopia
Background
Depression and tuberculosis are important global public
health concerns, contributing 2.5% and 2.0%, respect-
ively to Global Burden of Disease (GBD), as measured
by Disability Adjusted Life Years (DALYs) in 2010 [1]. In
the same year, depression together with other mental
and substance use disorders contributed 7.4% to the
total DALYs; TB together with HIV/AIDS contributed
5.3% to the total DALYs [2]. Both depression and TB
have substantial contributions to the burden of disease
in Ethiopia. Prevalence estimates of depression range
from about 5% in large sample population studies [3, 4]
to 9.1% in a nationally representative sample [5].
Ethiopia is one of the 22 countries that collectively ac-
count for 81% of all cases and 80% of all deaths from TB
worldwide [6]. In 2013, TB was the fourth highest con-
tributor to DALYs in the country [7].
Evidence from cross-sectional studies in both high in-
come [8] and low and middle income countries [9–17]
indicates a very high prevalence of co-morbid depression
among people with TB. The direction of causality is cur-
rently unclear and is likely to be complex. However, a
large longitudinal study in Taiwan found that newly di-
agnosed pulmonary TB patients on treatment were at
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higher risk of developing depression compared to healthy
controls after a mean period of 6.5 years [18]. Co-morbid
depression worsens the course of medical disorders and
has an adverse impact upon the quality of patient-
physician relationships [19]. People with co-morbid
depression are less satisfied with their primary care physi-
cians, making more health care visits for vague symptoms
but delaying visits for important medical problems and
missing essential scheduled visits [20]. Little is known
about the burden and impact of co-morbidity in Ethiopia.
In fact, overall, the evidence base on TB and depression
is sparse. The design of published studies, many of which
are small, cross-sectional and carried out among inpatients,
limits interpretation and generalisability of findings. For ex-
ample, hospital samples consist of severely ill patients with
additional significant stress from being hospitalized; there-
fore, conclusions may not apply to primary care patients.
All previous studies included TB patients on unspecified
medication which could lead to confounding. Finally, the
challenge of overlapping symptoms of somatised depression
and TB has not been adequately addressed. Weight loss,
loss of appetite, and fatigue are characteristic of both TB
and somatic symptoms of depression [21]. The latest Diag-
nostic and Statistical Manual of Mental Disorders (DSM-5)
states that such symptoms may not count towards a major
depressive disorder diagnosis when they are “clearly and
fully attributable” to a general medical condition [22]. Given
that co-morbid depression has been shown to be associated
with a range of adverse outcomes [20], we would argue that
it is important to try to separate depressive symptoms from
those of TB, in order that, ultimately, these may be detected
and treated in the context of TB services.
To better understand the burden and presentation of
depression in the context of TB, the objectives of this
study were to: a) determine the prevalence of depression;
b) examine the relative frequency of individual depres-
sive symptoms, and d) investigate associations with
socio-demographic and TB-related factors.
Methods
Design
We present cross-sectional baseline data from an on-
going cohort study investigating the interaction between
depression and tuberculosis in primary care settings in
Ethiopia. For a detailed description of methodology see
the published protocol [23].
Study setting
The study was conducted in five districts of the Southern
Nations, Nationalities and Peoples’ Region (SNNPR) of
Ethiopia namely, Butajira town, Mareko, Meskan, and
Sodo districts of Gurage zone, and Silti district of Silte
zone from December 2014 to January 2016. We had ex-
pected to find enough sample size in the above districts in
the specified study period, but due to lower than expected
numbers of new cases of TB in these sites, we included
five additional primary care centres from Bahir Dar and
Woreta towns of Amhara National Regional State in the
Northwest part of the country from June 2015.
Integrated mental health services were available in all
of the primary care centres included in this study.
Nurses and health officers are the main clinicians in
these settings that provide curative services to the com-
munity. All of these health workers in these health facil-
ities had received brief training in the management of
priority mental disorders according to the evidence-
based WHO Mental Health Gap Action Programme
Intervention Guide (mhGAP-IG) for mental, neuro-
logical and substance use disorders in non-specialized
health care settings [24].
Inclusion criteria
– People attending the selected health centres for TB
treatment who were within one month of starting
anti-TB treatment
– Aged 18 years and above
Exclusion criteria
– People planning to move out of the study area
– Those too ill to be interviewed at baseline: as
perceived by the interviewer or the prospective
participant
– Those who were admitted to in-patient unit for more
than 5 days in the last 1 month: as the additional
stressors of being hospitalized represent a different
range of risk factors for depression.
– People with MDR-TB, who constitute a different
population because their treatment and outcomes are
different (more toxic medications for a much longer
duration and poorer prognosis) and MDR-TB is a more
feared and stigmatised condition [25]. Furthermore,
only one of the study health facilities had recently
started a service for people with MDR-TB.
– People on re-treatment for TB, who had experienced
previous treatment failures, were at high risk of
MDR-TB and constituted a different risk group for
depression.
Sample size determination
The sample size was based on the primary objective of
the planned longitudinal study which was to examine
the effect of depression on default from anti-TB treat-
ment [23] and was calculated using the following param-
eters: 80% power, 95% confidence level, 2.5% prevalence
of treatment default among patients with TB and with-
out depression, 7.5% prevalence of treatment default
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among people with TB and co-morbid depression, a ra-
tio of 2:1 of non-exposed (not depressed) to exposed
(depressed) participants (n = 639) and a contingency of
10% for possible loss to follow up. This gave a required
sample size of 703 people with TB. A total of 657 partici-
pants were recruited due to scarcity of cases that met
our selection criteria.
Sampling technique
All illegible individuals were invited to participate in the
study consecutively until the required sample size was
reached. A total of 965 individuals visited the selected
health institutions for TB care during our study period
(13 months). Three hundred four of them were excluded
using our exclusion criteria: under age (n = 145), plan of
transfer out (n = 21), taken anti-TB medications for more
than one month (n = 31), admitted for more than five days
over the last one month (n = 30), confirmed to have
MDR-TB (n = 11), on retreatment regimen (n = 57), and
did not speak the language (n = 9). Of the 661 individuals
illegible for the study, four individuals (0.61%) refused to
participate in our study. The long duration of consecutive
recruitment from multiple health facilities with almost all
illegible individuals included makes our sample fairly rep-
resentative of adults newly diagnosed with TB.
Recruitment and data collection
The clinicians running TB outpatient clinics screened
people for eligibility, explained the research project and
invited them to participate in the study. When the per-
son expressed interest to participate, the workers linked
them to a trained nurse research assistant who gave fur-
ther detailed information, sought written consent and
carried out the baseline interviews. The nurse research
assistants were fulltime employees responsible for data
collection. Interviews were mostly conducted at the pri-
mary care health facility using a structured and pre-
coded questionnaire translated into Amharic. A small
number of participants (n = 13) were interviewed at their
homes as this was their expressed preference.
The clinicians and the nurse research assistants received
a five days training on: how to approach respondents and
obtain consent; administration of questionnaires, and eth-
ical principles of research. The training involved role plays
and practice with people who were attending TB clinic.
Video records of the role plays were used to facilitate
learning. A further five days refresher training was given
after six months.
Variables and measurement
The dependent variable was probable depression mea-
sured using the Patient Health Questionnaire (PHQ-9).
PHQ-9 is in widespread use in both research and clinical
practice. The scale has been used in very large surveys,
randomized effectiveness trials and cohort studies as
well as in different settings and population groups [26].
We have used the term depression to mean probable de-
pression for the purpose of simplicity.
The Amharic version of the scale has been formally
validated in Ethiopia in two separate studies. The first val-
idation was conducted in a large sample of medical out-
patients in a tertiary referral hospital in Addis Ababa [27].
In that study, PHQ-9 was found to be unidimensional
(one factor structure) and, at an optimal cut-off point for
major depressive disorder (MDD) of 10 and above, sensi-
tivity was 86% and specificity 67% [27]. The second PHQ-
9 validation was conducted in attendees of primary care
out-patient clinics in a predominantly rural area [28]. In
this study, PHQ-9 had a sensitivity of 0.83 and specificity
of 0.75 for detection of major depressive disorder (MDD)
at a cut-off value of five or more [28]. In the current study,
we opted to use the more conservative cut-off point of ten
and above to define probable depression because of con-
cerns about overlap of symptoms between tuberculosis
and the somatic symptoms of depression included in
PHQ-9 (loss of appetite, weight loss and fatigue) [21].
Independent variables
Socio-demographic variables
Age, sex, marital status, level of education, religion, house-
hold income, occupation, and place of residence (urban ver-
sus rural) were socio-demographic independent variables
used in the analysis. Household income was measured by
asking the participants to estimate the monthly total in-
come of their household. When the participant was a
farmer, we changed the estimates of annual income in kind
to cash using the local market price. We converted the
monthly income into annual income.
Symptoms of tuberculosis
Fever, night sweating, anorexia, fatigue, cough, and pain
were each scored from zero (absence of symptom) to ten
(worst level of symptom severity) as perceived by the re-
spondent for that week. The responses were then cate-
gorised as follows: no symptom (0), mild (1 to 4),
moderate (5 to 6), and severe (7 to 10), using a visual
analogue scale to indicate intensity, as recommended by
Jones et al. [29]. The duration of TB symptoms was cap-
tured by asking the respondents “how long did your TB
symptoms last before your illness was diagnosed as TB?”
Duration of anti-TB treatment
It was calculated from the date of starting the medications
which was found from the standard TB register and the
date of interview.
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Body Mass Index (BMI)
Weight and height were measured using standard proce-
dures. BMI was calculated as weight (kilograms)/height
(metres2). BMI values < 18.5 kg/m2 were defined as
underweight [30].
Substance use
Alcohol, tobacco and khat use were measured using the
WHO Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) (version 3.1) [31]. ASSIST was
designed for use across different cultural settings. The in-
strument’s psychometric properties have been tested using
data from multiple countries, including low, middle, and
high income countries and shown to be valid, reliable and
easy to administer across settings [32]. The ASSIST risk
score ranges from 0 to 31 for tobacco and 0–39 for alcohol
and khat. The risk score of the respondents obtained for
alcohol is categorised into ‘low’ (0 to 10), ‘moderate’ (11 to
26) or ‘high’ risk (above 26), and for khat low (0 to 3),
moderate (4 to 26) and high (above 26) [31].
Co-morbid illness
Data on the presence of chronic illnesses other than TB
were obtained by asking the question “Have you ever
been told by health professionals to have cardiac illness,
hypertension, diabetes mellitus, depression, or mental ill-
nesses other than depression?” HIV status was recorded
from the TB register after informed consent.
Perceived social support
Perceived social support was measured using the three-
item Oslo Scale of Perceived Social Support with scores
ranging from 3 to 14 [33]. The scale was previously re-
ported to work well in Ethiopia in TB patients [15]. The
Z-score of the scale total was cut into three equal parts
and then operationalized as poor, moderate and strong
perceived social support.
Data management
We have followed Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) guidelines for
cross-sectional studies [34]. All instruments were piloted
in 68 people with TB who were not included in the main
study where clarity, acceptability, and feasibility of the
baseline questionnaire were checked. The principal inves-
tigator made regular visits to the field to monitor data col-
lection. The health institutions were visited at least once
every two weeks to make sure that the data collection was
going as planned, and supervision meetings were held
with data collectors and supervisors at least every month.
The collected data were checked for completeness and
consistency by the supervisors in the field. Data were en-
tered by the principal investigator within a week using
IBM SPSS 20.0 (IBM Corp. Released 2011. IBM SPSS
Statistics for Windows, Version 20.0. Armonk, NY: IBM
Corp.). Accuracy of data entry was checked by running
frequency analysis and making range checks every time
data were entered. Errors of data entry were corrected by
cross-checking with the filled questionnaires. Dates for
second and third round assessments for each participant
were calculated by the principal investigator using SPSS
and passed on to supervisors and data collectors so that
they were able to arrange data collection.
Data analysis
Analysis was done using STATA version 13.1 (StataCorp.
URL:http://www.stata.com). We have tried to determine
whether the somatic symptoms of depression were meas-
uring the same underlying construct as the cognitive and
emotion symptoms. In preparation for factor analysis, we
checked PHQ-9 data for presence of adequate correlations
among items and adequacy of sample. We then carried
out exploratory factor analysis with maximum likelihood
extraction and oblimin rotation. Three criteria were used
to determine the number of factors extracted: eigen value
above one, scree plot and parallel analysis. Internal
consistency was checked using Cronbach’s alpha and
mean inter-item correlation coefficient.
The prevalence of probable depression among TB pa-
tients at baseline was determined by computing the pro-
portion of patients scoring 10 or more on the PHQ-9
scale. As recommended for analyzing prevalence ratios in
cross-sectional binary outcome studies where the outcome
is common [35–37], the factors associated with depression
at baseline were examined using both bivariate and multi-
variable Poisson regression with robust variance estimator.
Because the study sites were located in two regions of the
country, adjustment was made to the standard errors dur-
ing analysis. The inclusion of independent variables in the
multivariable analysis was based on: a) its theoretical im-
portance and b) adequacy of the number of participants in
cells for each category. In order to estimate the magnitude
of variance contributed by TB symptoms above and be-
yond socio-demographic factors, hierarchical multiple re-
gression was carried out by using the PHQ-9 scores as a
continuous dependent variable. In this analysis, the phys-
ical symptoms of TB (cough, night sweating, BMI, dur-
ation of TB symptoms, duration of anti-TB treatment, and
pain) were modelled in the second block after modelling
for socio-demographic variables in the first block as rec-
ommended by Tabachnic and Fidell [38]. Although loss of
appetite and fatigue are symptoms of TB, they were not
included in the multivariable model because the PHQ-9
has these same items. The necessary assumptions were
checked before running regression analyses.
The frequency of depressive symptoms that occurred
everyday for the whole two weeks was computed and
ranked.
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Results
Socio-demographic characteristics of the participants
This study included 657 people newly diagnosed with
TB, aged 18 to 85 years (median = 30; interquartile
range = 16). Three hundred five (46.4%) were under 30,
more than half (54.2%) were male, 227 (34.6%) were
non-literate, 365 (55.6%) were married, 409 (62.3%) were
Orthodox Christians, 310 (47.2%) were Amhara by eth-
nicity, 176 (26.8%) were farmers, 370 (56.3%) were urban
residents, and 557 (84.5%) were earning less than one
USD per day (Table 1).
Illness characteristics of the participants
Participants reported that they had been ill with symp-
toms of TB for 0.3 to 520.0 weeks (median = 12.0 weeks).
At the time of this study, 422 (64.2%) had never taken
anti-TB medication (median duration of anti-TB medica-
tion = 0; range = 0 to 27 days). In addition to TB, 75
(11.4%) had HIV, and 11 participants reported having
other co-morbid chronic illnesses: hypertension (n = 2),
cardiac illness (n = 3), diabetes mellitus (n = 5), and men-
tal illness other than depression (n = 1). No participant
had been diagnosed with depression prior to the study
(Table 2).
Prevalence of depression and burden of depressive
symptoms
The prevalence of probable depression in people with
TB using a cut-off value of ten and above was 54.0%
(95%CI = 50.2, 57.7%). The prevalence was slightly
higher in women (58.1%; 95%CI = 52.5, 63.8%) compared
to men (50.6%; 95%CI = 45.5, 55.6%). Little interest or
pleasure in doing things (73.0%), fatigue (64.5%), appe-
tite change (51.3%), sleep disturbance (38.9%), depressed
mood (36.9%), psychomotor disturbance (27.9%), feeling
bad or failure (23.4%), difficulty to concentrate (21.7%),
and suicidality (8.2%) were the rank of frequency of
symptoms in participants with probable depression. In
participants who did not have probable depression the
rank of frequency of symptoms was loss of interest
Table 1 Socio-demographic characteristics of the study
participants
Characteristics Number (%)
Sex
Male 356 (54.2)
Female 301 (45.8)
Age
18–29 years 305 (46.4)
30–39 years 161 (24.5)
40–49 years 75 (11.4)
50–59 years 52 (7.9)
60–69 years 35 (5.3)
70–79 years 17 (2.6)
80–89 years 12 (1.8)
Level of education
Unable to read and write 227 (34.6)
Able to read & write only 71 (10.8)
Grade 1–4 74 (11.3)
Grade 5–8 118 (18.0)
Grade 9–12 106 (16.1)
College graduate 61 (9.3)
Marital status
Single 214 (32.6)
Married 365 (55.6)
Divorced 47 (7.2)
Widow 31 (4.7)
Residence
Urban 370 (56.3)
Rural 287 (43.7)
Occupation
Government employee 62 (9.4)
Unemployed 37 (5.6)
Self-employed 134 (20.4)
Farmer 176 (26.8)
Student 40 (6.1)
Housewife 111 (16.9)
Daily labourer 44 (6.7)
Others 53 (8.1)
Religion
Orthodox 409 (62.3)
Islam 222 (33.8)
Protestant 23 (3.5)
Catholic 2 (0.3)
Other 1 (0 .2)
Ethnicity
Amhara 310 (47.2)
Table 1 Socio-demographic characteristics of the study
participants (Continued)
Gurage 194 (29.5)
Mareko 69 (10.5)
Silte 67 (10.2)
Oromo 11 (1.7)
Other 6 (0.9)
Income
< 1USD/person/day 557 (84.5)
≥ 1USD/person/day 100 (15.2)
Annual household income in Birr 13300 ± 14000
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(20.2%), fatigue (11.6%), appetite change (9.9%), sleep
disturbance (4.6%), depressed mood (4.0%), feeling bad
or failure (2.0%), psychomotor disturbance (1.0%), and
difficulty to concentrate (0.3%); none of them had sui-
cide ideation. The cognitive symptoms were observed al-
most exclusively in people with probable depression.
The characteristics of PHQ-9 in TB patients
PHQ-9 had a clear single structure explaining 35.0% of
the variance on the basis of the scree plot, eigen values
and parallel analysis. The scale had an alpha value of
0.81, and a mean inter-item correlation coefficient of
0.33. The loadings of the items ranged from 0.50 for ap-
petite change to 0.73 for psychomotor disturbance.
Socio-demographic variables associated with depression
Analysis was conducted with data from 644 participants
due to missing measures of BMI for 13 participants. In the
bivariate analyses, female sex, older age, lower educational
status, rural residence, lower household income, poor per-
ceived social support, and marital experience (married,
divorced or widowed compared to single) were associated
with increased prevalence of depression (p < 0.01). In the
multivariable model adjusted for socio-demographic vari-
ables, women had 23.0% increased risk of depression com-
pared to men (Adjusted Prevalence Ratio (APR) =1.23;
95%CI = 1.18, 1.27). For every 14 years increase in age, the
risk of having depression increased by 19.0% (95%CI = 1.06,
1.33). Attaining secondary education or higher (APR = 0.93;
95%CI = 0.90, 0.95) and strong perceived social support
(APR = 0.89; 95%CI = 0.85, 0.93) were found to be nega-
tively associated with depression (Table 3).
Tuberculosis symptoms and depression
In the bivariate analysis, all TB related variables except
duration of anti-TB treatment were associated with de-
pression (p < 0.05). In the final model where adjustment
was made for socio-demographic variables and TB
symptoms, night sweating (APR = 1.25; 95%CI = 1.16,
1.35), pain (APR = 1.69; 95%CI = 1.24, 2.29), underweight
(APR = 1.10; 95%CI = 1.07, 1.13), and longer duration of
illness with TB (APR = 1.35; 95%CI = 1.22, 1.50) were inde-
pendently associated with depression (Table 3). In a hier-
archical multiple linear regression analysis, TB symptoms
together explained 12.4% of variance of depressive symp-
toms after controlling for socio-demographic variables.
Discussion
Prevalence of depression
The overall prevalence of probable depression was 54.0%
which is higher than reported in a study that used the de-
pression component of the hospital anxiety and depres-
sion scale which was 43.4% in Ethiopian TB patients on
treatment [15]. Similar high prevalence was reported from
Nigeria [9, 17], India [10] and Turkey [12] regardless of
whether structured diagnostic tools [17] or screening in-
struments such as PHQ-9 [9] were used.
Depressive symptoms in people with TB
The clear one factor structure and the high internal
consistency of PHQ-9 support the notion that both the
somatic and the cognitive-emotion symptoms of depres-
sion are measuring the same underlying construct in
people with TB [39–41]. The individual item-factor corre-
lations ranged from 0.50 to 0.73 (fair to excellent) [38].
Previous PHQ-9 validation studies from Ethiopia also sup-
port unidimensionality of the scale [27, 28]. These findings
indicate that the potential overlap between TB symptoms
and somatic symptoms of depression may not significantly
compromise the construct validity of the tool.
Close observation of the frequency of depressive
symptoms would also suggest that the occurrence of the
symptoms in people with TB is in the usual manifestation
of the disorder. Basically, depression is known to have
multiple somatic symptoms together with psychological
Table 2 Illness related characteristics of the respondents
Characteristics Number (%)
Duration of TB symptoms)
< 2 weeks 92 (14.0)
2–12 weeks 289 (44.0)
13–52 weeks 214 (32.6)
> 52 weeks 62 (9.4)
Duration of anti-TB medication before interview)
No medication 422 (64.2)
1–3 days 130 (19.8)
> 3 days 105 (16.0)
HIV status
Positive 75 (11.4)
Negative 502 (76.4)
Unknown 80 (12.2)
Level of alcohol risk
Low 568 (86.5)
Moderate 77 (11.7)
High 12 (1.8)
Level of tobacco risk
Low 624 (95)
Moderate 29 (4.4)
High 4 (0.6)
Level of khat risk
Low 553 (84.2)
Moderate 93 (14.2)
High 11 (1.7)
Ambaw et al. BMC Psychiatry  (2017) 17:57 Page 6 of 10
Table 3 Factors associated with depression in people with newly diagnosed TB
Characteristics Depression status Crude Prevalence
Ratio (CPR) (95%CI)
AdjustedaPrevalen-ce
Ratio (APR) (95%CI)
No Yes
Sex
Male 174 172 1 1
Female 124 174 1.17 (1.16–1.19)*** 1.23 (1.18–1.27)***
Age (Z-score; SD = 14): 30.7 ± 11.5 37.7 ± 16.3 1.22 (1.07–1.39)** 1.19 (1.06–1.33)**
Level of education
No formal education 105 186 1 1
Primary education 89 101 0.83 (0.82–0.85)*** 1.09 (1.01–1.18)*
Secondary education or higher 104 59 0.57 (0.53–0.60)*** 0.93 (0.90–0.95)***
Residence
Urban 198 162 1 1
Rural 100 184 1.44 (1.13–1.84)** 1.22 (0.91–1.64)
Religion
Christian 225 198 1 1
Muslim 73 148 1.43 (0.97–2.11) 1.23 (0.79–1.92)
HIV status
Negative 235 260 1 1
Positive 31 40 1.07 (0.67–1.71) 1.33 (0.81–2.17)
Unknown 32 46 1.12 (0.95–1.32) 1.11 (0.88–1.40)
Annual household income (Z-scores; SD = 657USD): 22 USD ± 27 12.7 USD ± 18 0.78 (0.68–0.88)*** 0.87 (0.74–1.02)
Marital status
Single 124 85 1 1
Married 144 216 1.48 (1.18–1.84)** 1.06 (0.65–1.71)
Divorced or widow 30 45 1.48 (1.32–1.65)*** 0.97 (0.72–1.32)
Perceived social support
Poor 79 135 1 1
Moderate 121 112 0.76 (0.72–0.81)*** 0.83 (0.79–0.88)***
Strong 98 99 0.80 (0.72–0.88)*** 0.89 (0.85–0.93)***
Cough
No cough 135 69 1 1
Mild-to-moderate cough 123 139 1.57 (0.90–2.73) 1.40 (0.92–2.12)
Severe cough 40 138 2.29 (1.07–4.90)* 1.53 (0.88–2.68)
Night sweating
No night sweating 124 75 1 1
Mild-to-moderate night sweating 129 145 1.40 (1.11–1.77)** 1.21 (1.12–1.32)***
Severe night sweating 45 126 1.96 (1.53–2.49)** 1.25 (1.16–1.35)***
Duration of anti-TB medication
Never taken medication 190 227 1 1
1–3 days medication 60 68 0.98 (0.76–1.26) 0.97 (0.71–1.31)
More than 3 days medication 48 51 0.95 (0.60–1.50) 1.14 (0.77–1.69)
Duration of TB symptoms:
Less than 2 weeks 57 34 1 1
2–12weeks 121 159 1.52 (1.36–1.69)*** 1.40 (1.19–1.66)***
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symptoms as important elements for diagnosis [42].
Sometimes the presenting complaints of depressed mood
are insomnia [43] and fatigue [42] resulting in under diag-
nosis if probing is not done for accompanying depressive
symptoms [22]. Because PHQ-9 does not allow probing of
respondents, lower frequency of depressed mood com-
pared to anhedonia could be expected in our study. Simi-
larly, psychomotor disturbances are much less common in
patients with depression but are indicative of greater over-
all severity when they exist [22]. Although the observed
high frequency of somatic symptoms could be partly ex-
plained by the physical illness [44], somatic symptoms are
also very likely to constitute the presenting complaint of
depression [22, 42, 45] particularly when they are persist-
ent and their onset coincides with the onset of depressed
mood or anhedonia [44]. In this analysis, we considered
the symptoms when they occurred throughout the two
weeks prior to the survey.
Factors associated with depression
The common factors known to be associated with de-
pression in the general population have been found to
show significant associations with depression in people
with TB indicating the convergent validity of PHQ-9 in
this population. Our study is in agreement with previous
studies which reported that female sex [46, 47] and older
age [5, 48] were positively associated with depression
whereas level of education [49, 50] and perceived social
support [51] were negatively associated with depression.
In agreement with studies conducted in Nigeria [17]
and Greece [14], after controlling for socio-demographic
factors, BMI, night sweating, pain, and the duration of
these symptoms were associated with depression. In our
cross-sectional study, the exact nature of the association
between depression and TB symptoms is difficult to dis-
entangle. One possible explanation is that patients may
develop depression as a result of chronic TB infection,
related psycho-socio-economic stressors and general fac-
tors such as weight loss [52], and the severity of medical
illness [53]. Serious medical illness is a strong stressor
affecting body image, self-esteem, capacity to maintain
family and social relationships, and sense of loss [52, 54].
The association between depression and the severity of
TB symptoms could also be because depression in-
creases the severity of symptoms of physical illness [22].
Finally, depression and TB are likely to share risk fac-
tors, such as compromised immunity and stress [55–57].
The observed total explained variance of 12.4% by all TB
symptoms together which is below the margin of moder-
ate effect [58] may strengthen the hypothesis that TB
and depression may share risk factors significantly. Al-
though we are unable to disentangle the direction of the
association between depressive and TB symptoms in our
current analysis of cross-sectional data, our longitudinal
data will enable us to explore the temporal relationship
further in future analyses.
Strengths and limitations
Unlike all previous studies, this study had sufficient sam-
ple size for both exploratory factor analysis and controlled
regression analysis. We were able to control for the effects
of anti-TB medications, as some of the participants did
not take medication at all at the time of baseline assess-
ment. In an effort to obtain a more homogenous sample,
we focused on primary care patients. We assessed the
relative burden of specific depressive symptoms and the
usefulness of somatic symptoms of depression in the con-
text of TB.
In addition to the cross-sectional design, we used a
screening tool which has been validated in Ethiopia in out-
patient populations but not validated specifically among
TB patients. There is overlap between the symptoms of
TB and depression. The overlap in the symptoms of TB
and some items of PHQ-9 might have led to over
classification of cases as depression with the resultant
weakening effect on the association between depres-
sion and the independent variables. Therefore, we
opted to classify our cases as high and low symptom
scorers and we have used a conservative cut-off to in-
crease its specificity. Post hoc analysis of the scale
Table 3 Factors associated with depression in people with newly diagnosed TB (Continued)
More than 12–52 weeks 93 118 1.50 (1.15–1.94)** 1.40 (1.00–1.94)
More than 52 weeks 27 35 1.51 (1.19–1.92)** 1.35 (1.22–1.50)***
BMI
Not underweight 154 131 1 1
Underweight 144 215 1.30 (1.02–1.66)* 1.10 (1.07–1.13)*
Pain
No pain 37 17 1 1
Mild-to-moderate pain 195 122 1.22 (0.96–1.56) 1.09 (0.99–1.21)
Severe pain 66 207 2.41 (1.50–3.87)*** 1.69 (1.24–2.29)***
A adjustment was made for all variables in the table; * = p < 0.05; ** = p < 0.01; *** = p < 0.001
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characteristics in our sample has also indicated con-
ventional performance of the scale in our sample.
Conclusions
We found probable depression to be highly prevalent
among our sample of adult people newly diagnosed with
TB in primary care settings. Our findings suggest that it
may be appropriate for clinicians and researchers to include
somatic symptoms of depression in their assessments of TB
patients for depression provided that the affective and cog-
nitive symptoms are present. The single factor structure of
PHQ-9 results, good internal consistency and the familiar
manifestations of symptomatology suggest that the PHQ-9
may be suitable for detecting depression in the context of
TB. However, the predictive validity of the scale needs to be
determined. The duration and severity of TB symptoms
were important factors independently associated with de-
pression after socio-demographic factors were controlled.
Prospective studies are needed to understand the longitu-
dinal relationship between TB symptoms, depressive symp-
toms and TB outcomes.
Highlights
 Depression was prevalent in untreated newly
diagnosed tuberculosis (TB) patients.
 The commonest symptom of co-morbid depression
in TB patients was anhedonia.
 The burden of depressive symptoms in co-morbid
patients was similar to the familiar manifestation of
the disorder.
 Somatic symptoms show depression if affective and
cognitive symptoms are there.
 TB symptoms as a group explain 12.0% of the
variance in predicting depression.
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